1-3 of 3
Olivier Nibourel, PharmD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ABCA3 Expression Predicts Response to Gemtuzumab Ozogamicin in AML

Antony Ceraulo, Aminetou Mint-Mohamed, Delphine Maucort-Boulch, MD PhD, Etienne Paubelle, MD PhD, Xavier Thomas, MD PhD, Lea Herpe, Olivier Nibourel, PharmD, PhD, Claude Preudhomme, MD PhD, Sylvie Castaigne, MD PhD, Hervé Dombret, Eric Wattel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3946.
https://doi.org/10.1182/blood.V128.22.3946.3946
Published: 2016
Journal Articles

Age and Gemtuzumab Ozogamicin Influence the Prognostic Impact of TET2 Expression and Splicing in Intensively Treated Patients with Acute Myeloid Leukemia

Antony Ceraulo, Aminetou Mint-Mohamed, Delphine Maucort-Boulch, MD PhD, Helene Lapillone, Guy Leverger, MD, Etienne Paubelle, MD PhD, Xavier Thomas, MD PhD, Olivier Nibourel, PharmD, PhD, Claude Preudhomme, MD PhD, Sylvie Castaigne, MD PhD, Hervé Dombret, Lea Herpe, Christine Ragu, PhD, Yves Bertrand, MD PhD, Franck Mortreux, PhD, Eric Wattel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3952.
https://doi.org/10.1182/blood.V128.22.3952.3952
Published: 2016
Journal Articles

De Novo and Secondary Acute Myeloid Leukemia, Real World Data on Outcomes from the French Nord-Pas-De-Calais Picardie Acute Myeloid Leukemia Observatory

Loïc Renaud, Olivier Nibourel, PharmD, PhD, Celine Berthon, Christophe Roumier, Céline Rodriguez, Cecile Frimat, Catherine Roche-Lestienne, Aline Renneville, MD, Bruno Quesnel, MD PhD, Claude Preudhomme, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4013.
https://doi.org/10.1182/blood.V128.22.4013.4013
Published: 2016